CGAS and hepatocellular carcinoma: Du et al. reported that radiotherapy upregulated PD-L1 expression in HCC by activating the intrinsic cGAS-STING pathway, leading to immune evasion; therefore, combination therapy with anti-PD-L1 blockade potentiated the antitumor effect of radiotherapy [82].